Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions: Pulmonary Disease; Tuberculosis, Pulmonary; Tuberculosis; Multi Drug Resistant Tuberculosis; Drug Sensitive Tuberculosis; Drug-resistant Tuberculosis; Mycobacterium Tuberculosis Infection Interventions: Drug: TBAJ-876 10mg; Drug: TBAJ-876 25mg; Drug: TBAJ-876 50mg; Drug: TBAJ-876 100mg; Drug: TBAJ-876 200mg; Drug: TBAJ-876 400mg; Drug: TBAJ-876 Dose XXXmg for Food cohort; Drug: TBAJ-876 XXXmg for Part 2; Drug: Matching Placebo for TBAJ-876 tab let Sponsor: Global Alliance for TB Drug Development Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Tuberculosis